Deepti Pandita | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Prof. Deepti Pandita | Pharmacology | Best Researcher Award

Prof. Deepti Pandita, Delhi Pharmaceutical Sciences & Research University, New Delhi, India

Prof. Deepti Pandita is a distinguished academic and professional serving as a Professor at the Delhi Pharmaceutical Sciences & Research University (DPSRU), New Delhi, India, since May 2020. She holds key leadership roles as the PhD Coordinator and the Training & Placement Head at DPSRU, contributing significantly to academic administration and student career development.

Education

PhD in Pharmaceutics (2008)

Institution: Jamia Hamdard, Hamdard University, New Delhi

Thesis Topic: “Development and evaluation of submicron lipid nanoparticles for the oral delivery of paclitaxel”

Fellowship: ICMR – Senior Research Fellow (2005–2008)

Reference: SR/FT/LS145/2011

Master of Pharmacy in Pharmaceutics (2002)

Institution: Manipal College of Pharmaceutical Sciences, MAHE, Karnataka

Aggregate: 78.86%

Bachelor of Pharmacy (1997)

Institution: Mysore University, Karnataka

Aggregate: 74.59%

MBA in Marketing (2013)

Institution: M. D. University, Rohtak (Distance Mode)

Aggregate: 66.11%

Higher Secondary Education (XII Class) (1995)

Board: CBSE, Delhi

Aggregate: 63%

Secondary Education (X Class) (1993)

Board: CBSE, Delhi

Aggregate: 78%

Registered Pharmacist

Registration Number: 14991

Date: 11.10.2002

Issuing Authority: Delhi Pharmacy Council

Professional Profiles

Google Scholar

ORCID Profile

Professional Experience

Professor
Delhi Pharmaceutical Sciences & Research University (DPSRU), Govt. of NCT of Delhi, New Delhi, India
May 27, 2020 – Present

Associate Professor
Amity University Uttar Pradesh, Noida
June 4, 2018 – April 4, 2020

Professor & Head
JCDM College of Pharmacy, Sirsa
October 12, 2012 – June 1, 2018

Associate Professor & Head
JCDM College of Pharmacy, Sirsa
August 18, 2010 – October 11, 2012

Postdoctoral Fellow
CQM, University of Madeira, Portugal
June 1, 2008 – July 31, 2010

Assistant Professor
SBMN Institute of Pharmaceutical Sciences & Research, M.D. University, Rohtak
September 24, 2002 – July 31, 2003

Research Interests

Nanomedicine & Nanotheranostics

Bioconjugates

Stem Cell Research for Tissue Engineering

Drug Discovery & Repurposing

3D Printing for Personalized & Precision Medicine

Targeted Phytochemical Delivery

Top Notable Publications

Therapeutic Potential of Isoliquiritigenin in Breast Cancer

Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology (2024)

DOI: 10.1007/s00210-024-03282-6

Contributors: Divya Sharma, Mahaveer Dhobi, Viney Lather, Deepti Pandita

This research explores the therapeutic effects of isoliquiritigenin on breast cancer treatment.

 

CDC20 Inhibitors in Breast Cancer

Journal: 3 Biotech (2023)

DOI: 10.1007/s13205-023-03554-7

Contributors: Amiya Das, Hitesh Kumar Sharma, Viney Lather, Deepti Pandita, Pallavi Agarwal

Focuses on the identification and evaluation of CDC20 inhibitors as potential therapeutic agents for breast cancer.

 

Drug Repurposing for Triple-Negative Breast Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry (2022)

DOI: 10.2174/1871520621666211021143255

Contributors: Amiya Das, Pallavi Agarwal, Gaurav Kumar Jain, Geeta Aggarwal, Viney Lather, Deepti Pandita

Examines novel therapeutic options through drug repurposing for aggressive breast cancer types.

 

Protective Effects of Dalbergia sissoo

Journal: Turkish Journal of Pharmaceutical Sciences (2021)

DOI: 10.4274/tjps.galenos.2020.04379

Contributors: Raheja S., Girdhar A., Kamboj A., Lather V., Pandita D.

Studies the neuroprotective effects of Dalbergia sissoo against oxidative stress and memory impairment.

 

Phytoconstituents in COVID-19 Management

Journal: Chemico-Biological Interactions (2021)

DOI: 10.1016/j.cbi.2021.109449

Contributors: Das A., Pandita D., Jain G.K., Agarwal P., Grewal A.S., Khar R.K., Lather V.

Explores the potential of phytoconstituents in combating COVID-19.

 

Biomedical Applications of Extracellular Matrix Extraction Techniques

Journal: Regenerative Medicine (2021)

DOI: 10.2217/rme-2021-0021

Contributors: Kirthanashri S. Vasanthan, Varadharajan Srinivasan, Deepti Pandita

Discusses innovative extracellular matrix techniques for biomedical engineering.

 

Paclitaxel Hybrid Nanoparticles for Cancer Therapy

Journal: Materials Science and Engineering C (2020)

DOI: 10.1016/j.msec.2019.110576

Contributors: Godara S., Lather V., Kirthanashri S.V., Awasthi R., Pandita D.

Details advancements in lipid-PLGA nanoparticles for enhanced cancer treatment.

 

Cinnamic Acid Derivatives for Metabolic Syndrome

Journal: Current Drug Discovery Technologies (2020)

DOI: 10.2174/1570163816666190314124543

Contributors: Chauhan A., Grewal A.S., Pandita D., Lather V.

Investigates novel cinnamic acid derivatives as PPARδ agonists.

 

Methotrexate and Resveratrol Nanoemulsions

Journal: Assay and Drug Development Technologies (2020)

DOI: 10.1089/adt.2020.989

Contributors: Poonia N., Lather V., Kaur B., Kirthanashri S.V., Pandita D.

Optimizes nanoemulsions for rheumatoid arthritis treatment.

 

Resveratrol-Loaded Nanoparticles

Journal: Materials Science and Engineering C (2020)

DOI: 10.1016/j.msec.2020.111016

Contributors: Poonia N., Lather V., Narang J.K., Beg S., Pandita D.

Develops lipoprotein-mimetic nanoparticles for improved drug delivery systems.

Conclusion

Prof. Deepti Pandita is a highly deserving candidate for the “Research for Best Researcher Award,” with her strong foundation in impactful research, innovative methodologies, and multidisciplinary expertise. Her contributions to oncology, neuropharmacology, and drug delivery systems stand out as significant advancements in the field of pharmacology.

 

 

 

 

 

 

 

Jingyi Jin | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Mrs. Jingyi Jin | Pharmacology | Best Researcher Award

 

Research Assistant at Shuguang hospital affiliated to Shanghai University of Traditional Chinese Medicine, China

Mrs. Jingyi Jin is an accomplished researcher in the field of pharmacokinetics, with a strong academic background and extensive practical experience. She is currently pursuing her Master’s degree in Pharmacokinetics at the Shanghai University of Traditional Chinese Medicine, having previously earned a Master’s degree in the same field from Paris Descartes University. Her academic journey began with a Bachelor’s degree in Traditional Chinese Medicine from the Shanghai University of Traditional Chinese Medicine, where she graduated in the top 3% of her class. Mrs. Jin’s research has focused on the pharmacokinetics of traditional Chinese medicinal compounds, with notable projects including the study of Da-Huang-Xiao-Shi Decoction in mice, the transport mechanisms of venlafaxine and its metabolite in hCMEC/D3 cells, and the involvement of transport proteins in the efflux of berberine. Her work has provided valuable insights into drug interactions, bioavailability, and the optimization of combination therapies. In addition to her research, Mrs. Jin has developed a comprehensive skill set in experimental techniques, including animal handling, cell culture, transfection technology, and advanced analytical methods using mass spectrometry and liquid chromatography. Her dedication, responsibility, and logical thinking have been recognized through multiple awards and scholarships, underscoring her excellence as a student and researcher. Overall, Mrs. Jingyi Jin’s expertise in pharmacokinetics, combined with her practical skills and academic achievements, make her a significant contributor to the field of Traditional Chinese Medicine and modern pharmacology. Her work continues to advance our understanding of medicinal compounds and their therapeutic applications.

Professional Profiles:

📚 Education:

Mrs. Jingyi Jin has a strong academic background in the field of pharmacokinetics and Traditional Chinese Medicine. She is currently pursuing her Master’s degree in Pharmacokinetics at the Shanghai University of Traditional Chinese Medicine, where she has been studying since 2015. During this time, she has focused on the pharmacokinetics of traditional Chinese medicinal compounds, contributing to the advancement of this specialized field. In addition to her studies in China, Mrs. Jin furthered her expertise by obtaining a second Master’s degree in Pharmacokinetics from Paris Descartes University in 2018. This international experience provided her with a broader perspective and deeper understanding of pharmacokinetics, particularly in the context of Western and Chinese medicinal practices. Prior to her master’s studies, Mrs. Jin completed her Bachelor’s degree in Traditional Chinese Medicine at the Shanghai University of Traditional Chinese Medicine in 2015, graduating in the top 3% of her class. Her undergraduate education laid a solid foundation in both the theoretical and practical aspects of Traditional Chinese Medicine, which she has built upon through her advanced research and studies. This rigorous academic journey has equipped Mrs. Jin with the knowledge and skills necessary to excel in her field and contribute meaningfully to scientific research and development.

Research Interests:

Mrs. Jingyi Jin has made significant contributions to the field of pharmacokinetics through her extensive research endeavors. Since May 2018, she has been investigating the pharmacokinetics of Da-Huang-Xiao-Shi Decoction in mice, focusing on understanding the absorption, distribution, metabolism, and excretion of this traditional Chinese medicinal formulation. Her work aims to elucidate the pharmacological basis of its therapeutic effects and optimize its clinical use. From May 2017 to April 2018, Mrs. Jin studied the transport mechanisms of venlafaxine and its main metabolite, O-desmethylvenlafaxine, in hCMEC/D3 cells. This research was pivotal in understanding how these compounds cross the blood-brain barrier, providing insights into their efficacy and safety as antidepressants. Prior to this, she examined the involvement of P-glycoprotein and multidrug and toxin extrusion protein 1 in the hepatic and renal efflux of berberine in mice from September 2015 to April 2017. This study highlighted the roles of these transport proteins in drug-drug interactions and their impact on berberine’s bioavailability and therapeutic effectiveness. Mrs. Jin’s early research, conducted from December 2014 to August 2015, focused on the absorption interaction between berberine and metformin in vitro. This study explored the synergistic effects of these two compounds, commonly used in the treatment of type 2 diabetes, and provided a foundation for optimizing combination therapies. Through these diverse research projects, Mrs. Jin has demonstrated a robust ability to conduct detailed pharmacokinetic studies, contributing valuable knowledge to the field and enhancing the scientific understanding of traditional Chinese medicines and modern pharmaceuticals.

Skills:

Mrs. Jingyi Jin possesses a comprehensive set of experimental skills, honed through years of rigorous academic training and hands-on research experience. She is proficient in the routine operation of mice and rats, which includes handling, dosing, and sample collection. Her expertise in animal studies is complemented by her proficiency in cell culture techniques, where she excels in the cultivation and maintenance of various cell lines. Mrs. Jin is also skilled in transfection technology, enabling her to introduce foreign DNA into cells to study gene function and expression. In addition to these foundational skills, Mrs. Jin has mastered several advanced analytical techniques. She is experienced in conducting transport assays, which are critical for understanding the movement of substances across cell membranes. Her technical repertoire includes the use of sophisticated instruments such as the Thermo Scientific TSQ and LCQ mass spectrometers, and she is familiar with Ultra-Performance Liquid Chromatography (UPLC) and the 5500 QTRAP system. These skills are crucial for the establishment and validation of analytical methods used in pharmacokinetic studies. Mrs. Jin’s ability to integrate these diverse experimental techniques demonstrates her versatility and depth of knowledge in pharmacokinetics and drug metabolism. Her proficiency with both in vivo and in vitro models positions her as a valuable asset in the field of pharmacokinetics research, contributing to the advancement of our understanding of drug interactions and mechanisms.

 

📚Publications :

Gancao decoction attenuates hepatic necroptosis via activating caspase 8 in cholestatic liver injury

Authors: Zou, B., Zhang, S., Li, F., …, Li, Y., Qiu, F.

Journal: Journal of Ethnopharmacology

Year: 2024

Citations: 1

Simultaneous determination of 11 oral targeted antineoplastic drugs and 2 active metabolites by LC-MS/MS in human plasma and its application to therapeutic drug monitoring in cancer patients

Authors: Zhao, J., Yan, D., Li, Y., …, Jin, J., Qiu, F.

Journal: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Year: 2024

Citations: 0

Physiologically based pharmacokinetic modeling for confirming the role of CYP3A1/2 and P-glycoprotein in detoxification mechanism between glycyrrhizic acid and aconitine in rats

Authors: Jin, J., Xu, X., Li, F., …, Yan, D., Qiu, F.

Journal: Journal of Applied Toxicology

Year: 2024

Citations: 0

Glycyrrhetinic acid attenuates endoplasmic reticulum stress-induced hepatocyte apoptosis via CHOP/DR5/Caspase 8 pathway in cholestasis

Authors: Zou, B., Zhang, S., Zhao, J., …, Li, Y., Qiu, F.

Journal: European Journal of Pharmacology

Year: 2023

Citations: 2

Yinchen decoction protects against cholic acid diet-induced cholestatic liver injury in mice through liver and ileal FXR signaling

Authors: Song, G., Zou, B., Zhao, J., …, Liu, C., Qiu, F.

Journal: Journal of Ethnopharmacology

Year: 2023

Citations: 3

The choleretic role of tauroursodeoxycholic acid exacerbates alpha-naphthylisothiocyanate induced cholestatic liver injury through the FXR/BSEP pathway

Authors: Zhao, J., Song, G., Weng, F., …, Liu, C., Qiu, F.-R.

Journal: Journal of Applied Toxicology

Year: 2023

Citations: 1

Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway

Authors: Song, G., Weng, F., Zou, B., …, Li, Y., Qiu, F.

Journal: Clinical Science

Year: 2023

Citations: 5

15,16-dihydrotanshinone I in Danshen ethanol extract aggravated cholestasis by inhibiting Cyp3a11 mediated bile acids hydroxylation

Authors: Li, Y., Wang, Q., Jin, J., …, Yan, D., Qiu, F.

Journal: Toxicology Letters

Year: 2023

Citations: 1

Application progress of liquid chromatography tandem mass spectrometry in precision medicine

Authors: Jin, J., Qiu, F., Zhang, J.

Journal: Chinese Journal of Preventive Medicine

Year: 2022

Citations: 0

Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms

Authors: Wang, Q., Song, G.-C., Weng, F.-Y., …, Li, Y., Qiu, F.-R.

Journal: Frontiers in Pharmacology

Year: 2022

Citations: 11